NICE draft guidance recommends wider range of GP treatments for heart failure
GPs will be able to start prescribing a wider range of treatments for early stage chronic heart failure under new draft guidance from the National Institute for Health and Care Excellence (NICE).1 NICE recommends that GPs be able to prescribe, on the advice of a heart specialist, sodium-glucose cotransporter-2 (SGLT-2) inhibitors and angiotensin receptor neprilysin inhibitors (ARNIs) for patients who have heart failure with reduced ejection fraction (HFrEF), to help avoid unnecessary delays to treatment. An estimated 614 000 adults in England have heart failure, and around 63% of these have HFrEF, which occurs when the left side of the heart …
